使用敲除细胞株进行验证
重组
RabMAb

Anti-Tuberin抗体[Y320] (ab32554)

发表研究结果有使用 ab32554?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab32554 被引用在 10 文献中.

  • Pal R  et al. Inhibition of ERK1/2 Restores GSK3ß Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis. Sci Rep 7:4174 (2017). PubMed: 28646232
  • D'Armiento J  et al. Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation. Cancer Res 76:844-54 (2016). PubMed: 26837766
  • Guo C  et al. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget 6:11114-24 (2015). PubMed: 25798539
  • Parkhitko AA  et al. Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide. Mol Cancer Res 12:48-57 (2014). PubMed: 24296756
  • Zhang L  et al. TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice. PLoS One 7:e30592 (2012). WB . PubMed: 22363451
  • Hennessy BT  et al. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics 6:129-51 (2010). Dot blot ; Human . PubMed: 21691416
  • Alexander A  et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107:4153-8 (2010). PubMed: 20160076
  • Dere R  et al. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One 5:e9239 (2010). PubMed: 20169078
  • Hartman TR  et al. The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene 28:1594-604 (2009). WB ; Human . PubMed: 19234517
  • Kim WY  et al. A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy. Cancer Prev Res (Phila) 1:577-87 (2008). PubMed: 19139008

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册